The Fifth Chemical Congress of North America


Nov 11-15, 1997. Cancun, Quintana Roo, Mexico

SYMPOSIUM

Chemistry, Biochemistry and Therapeutic Applications of
Vanadium Compounds


FINAL PROGRAM


Wednesday Morning

Peter Schwendt, Presiding

9:00 a.m. ______ The Nutritional Essentiality and Physiological
Metabolism of Vanadium in Higher Animals. F. H. Nielsen

9:30 a.m. ______ Studies of Vanadate-Organic Ligand Systems
Using Potentiometry and NMR Spectroscopy. L. Pettersson

10:00 a.m. ______ Structural and Functional Models for Biogenic Vanadium Compounds. D. Rehder, M. Bashirpoor, S. Jantzen, H. Schmidt

10:30 a.m. ______ Synthesis, Structure and Reactivity of V(V)-Thiolate and V(V)-eta2-Sulfenate Complexes. C. R. Cornman, T. C. Stauffer, P. D. Boyle

10:50 a.m. ______ Selective Synthetic Transformations via
Vanadium-Induced Redox. T. Hirao

11:10 a.m. Intermission

11:20 a.m. ______ Vanadyl Cation as a Probe of Nucleotide and Protein Structure. S. Chen, H. Ruetthard, A. Banerjee, F. S. Jiang, M. Sprinzi, M. W. Makinen

11:50 a.m. ______ The Vanadyl Coordination Environment in Imidazole Glycerol Phosphate Dehydratase. J. Petersen, T. R. Hawkes, D. J. Lowe

12:10 p.m. ______ The Accumulation Mechanism of Vanadium by
Ascidians. H. Michibata, T. Uyama, K. Kanamori

Wednesday Afternoon,

J. Antonio Guevara-Garcia, Presiding

3:30 p.m. ______ Chloroperoxidase from Curvularia inaequalis: X-Ray Structures of Native and Peroxide Form Reveal Vanadium Chemistry in Vanadium Haloperoxidases. A. Messerschmidt, L. Prade, R. Wever

3:50 p.m. ______ Peroxidase Activity of Vanadium Haloperoxidase Model Compounds. C. Slebodnick, M. E. Gillis, B. J. Hamstra, V. L. Pecoraro

4:20 p.m. ______ Selectivity of Vanadium Bromoperoxidase with
Indole Derivatives. A. Butler, A. Baldwin, M. Simpson

4:50 p.m. ______ From Vanadium Haloperoxidases to Phosphatases, the Same Architecture for the Active Site. R. Wever, W. Hemrika, R. Renirie, P. Barnett, A. Messerschmidt, Henk Dekker

5:10 p.m. Intermission

5:20 p.m. ______ A New Class of Insulin-Mimetic Compounds: N,N-Dimethylhydroxamidovanadates, Aspects of Their Chemistry and Function. F. Nxumalo, A. S. Tracey

5:50 p.m. ______ New Peroxo- and Hydroxylamino Vanadium Complexes: Chemistry, Phosphatase Activity and Insulin Mimetic Properties. D. C. Crans

6:20 p.m. ______ Paradoxical Enhanced Sensitivity of Insulin Resistant Adipocytes to Vanadate is Associated with Decreased Intracellular Reduction of Vanadate(+5) to Vanadyl(+4). I. G. Fantus, B. Lu

6:40 p.m. ______ Vanadyl Sulfate (VS)-Induced Glycogen Synthesis in Chinese Hamster Ovary Cells Over-expressing Human Insulin Receptor (CHO-HIR Cells) is Blocked by Wortmannin and LY294002, Inhibitors of Phosphatidyl Inositol 3-Kinase (PI3-K). S. K. Pandey, M. B. Anand-Srivastava, A. K. Srivastava

Thursday Morning

, Debbie C. Crans, Presiding

9:00 a.m. ______ Coordination Chemistry of Insulin-Mimetic Vanadium Compounds. C. Orvig, J. H. McNeill

9:30 a.m. ______ On the Insulin-Like Effects of Vanadium Salts. Y. Shechter, E. Elberg, N. Sekar, Z.-B. He, D. Gefel, J. Meyerovitch, R. Bruck, E. Gershonov, A. Shishevia, D. C. Crans, R. Sigar, M. Fridkin, Y. Goldwasser, J. Li

10:00 a.m. Intermission

10:10 a.m. ______ Vanadium Bioactivity on Cells in Culture. S.
B. Etcheverry, A. M. Cortizo

10:40 a.m. ______ Mechanism of Action of Peroxovanadium
Compounds. B. I. Posner, A. Shaver

11:10 a.m. ______ Structure-Activity Relationships of the
Insulin-Mimetic Vanadyl Complexes. H. Sakurai

11:40 a.m. ______ Pharmacokinetics of Vanadium Following Repeated Oral Dosing with Vanadyl Sulfate in Patients with NIDDM. G. R. Willsky, A. B. Goldfine, C. R. Kahn, P. J. Kostyniak

12:00 p.m. ______ Vanadium Salts in the Treatment of Human
Diabetes Mellitus. C. R. Kahn, A. B. Goldfine

Wednesday Evening----Oral Poster session


Alan S. Tracey, Presiding

7:30 - 10:00 PM

___ Vanadium(V) Equilibria: Stability Constants and Thermodynamic
Quantities for the Various Ionic Species. J. J. Cruywagen

___Estimating Formation Constants for Vanadium(V)-Pentose
Complexes. D. C. Crans, F. Xin

___ Solution Chemistry of Bis(1,2-dimethyl-3-hydroxy-4-pyridinonate)oxo-vanadium(IV) in Water. M. Rangel, M. Castro, W. Schlindwein, R. Matias, B. Castro, C. Geraldes, J. Burgess

____ Synthesis and Characterization of Trigonal Bipyramidal Vanadyl Complexes: Structural and Electronic Constants on Molecular Geometry. C. R. Cornman, K. M. Geiser-Bush, P. D. Boyle

___ Reactions of Vanadate with Thiol Compounds: Complex Formation
and Redox Chemistry. D. C. Crans, B. Zhang

___ Composition and Structure of Vanadium(V) Peroxo Complexes. P. Schwendt, M. Sivak

___ From the Speciation of Peroxovanadium Complexes in Aqueous Solution to the Chemistry of Haloperoxidases. V. Conte, F. Di Furia, S. Moro

___ Bis(peroxo)oxovanadium(V) Complexes of Histidine-Containing Peptides as Models for Vanadium Halo-peroxidases. J. A. Guevara-Garcia, G. Mendoza-Diaz and N. Barba-Behrens

___ Vanadium Chloroperoxidase Models: Solvent Dependence of Chloride Oxidation Rates by Vanadate. C. Slebodnick, G. J. Colpas, V. L. Pecoraro

___ Catalytic Oxidations with Biomimetic Vanadium Systems. I. W.
Arends, R. A. Sheldon

___ The Applications of Vanadium Peroxidases as Novel Biocatalysts. H. B. ten Brink, W. Hemrika, H. L. Dekker, H. E. Schoemaker, R. Wever

___ Exploring the Active Site of Vanadium Chloroperoxidase. R.
Renirie, W. Hemrika, H. L. Dekker, P. Barnett, R. Wever, E. C. Slater

___ A Possible Role for Amavadine in Some Amanita Fungi. C. M. M. Matoso, A. J. L. Pombeiro, J. J. R. Frausto da Silva, M. F. C. Guedes da Silva, J. A. L. Silva

___ What is the Active Vanadium Species Inhibiting Growth of S. cerevisiae in High Phosphate Growth Medium? G. R. Willsky, D. C. Crans

___ Determination of the Vanadate-Mediated NAD(P)H or NADH Oxidation Mechanism by Superoxide Radical. I. Nieves-Martinez, C. J. Olivo-Delgado, R. P. Mason

___ Influence of Vanadate on Glycolysis, Intracellular Sodium and pH in Perfused Rat Hearts. C. F. G. C. Geraldes, M. M. C. A. Castro, R. Ramasamy, A. D. Sherry

___Vanadate and Pervanadate Stimulate Glucose Uptake in L6 Skeletal Muscle Cells by a Mechanism Independent on Phosphatidylinositol 3-Kinase and Protein Kinase. I. G. Fantus, E. Tsiani, A. Sorisky

___ New Vanadium Compounds in The Treatment of Diabetes-Induced Rats. J. A. Guevara-Garcia, E. B. Colombres, E. Gonzalez-Vergara, R. Tapia-Benavides, C. E. Weinmann

Further information concerning the Fifth NACC can be obtained from the ACS webpage http://www.acs.org/meetings/5nacc

The organizers of this symposium may be contacted for further
information:

Debbie C. Crans crans@lamar.colostate.edu
Colorado State University

Alan S. Tracey tracey@sfu.ca
Simon Fraser University

----------------------------------------

Alan S. Tracey Department of Chemistry and Institute of Molecular Biology and Biochemistry Simon Fraser University Burnaby, B.C., V5A 1S6 Canada --------- Tel (604) 291 4464 FAX (604) 291 3765 e_mail tracey@sfu.ca